Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
Communication
In the News
Presentations
Contact Us
Contact Us
Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
17 Dec 2020
Shareholder Update - 2020 Review
02 Dec 2020
Amplia Receives $0.53m R&D Tax Incentive
27 Nov 2020
Appendix 4D and Financial Report Half Year Ended 30 Sep 2020
24 Nov 2020
Appendix 2A - Allot Shares upon Exercise of Options
02 Nov 2020
Notice ASX LR 3.11.2 - Change of Exercise Price of Options
29 Oct 2020
ATX - Sep 2020 Quarter Activities and Cashflow Reports
21 Oct 2020
Amplia Presentation to Reach Market Services - Meet the CEO
20 Oct 2020
Response to ASX Price Query
08 Oct 2020
First Human Dose in Phase 1 Clinical Trial of AMP945
18 Sep 2020
Change of Director's Interest Notice - Dr. Warwick Tong
1
2
3
4
5
6
7
Next
